The following discussion contains forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact are statements that could be ...
Ozempic wins on affordability and accessibility, Mounjaro positions itself as a premium, high-efficacy option, while Wegovy remains the specialist brand for obesity.